跳至主要内容
临床试验/NCT02363894
NCT02363894已完成不适用

Directional AthErectomy Followed by a PaclItaxel-Coated BalloN to InhibiT RestenosIs and Maintain Vessel PatEncy: A Pilot Study of Anti-Restenosis Treatment - Two Year Follow-up Extension Study

Medtronic Endovascular0 个研究点目标入组 53 人开始时间: 2015年3月最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
53
主要终点
Major Adverse Event Rate

研究概览

简要总结

The purpose of this DEFINITIVE AR Two Year Follow-up Extension Study is to gather data to assess and estimate the long term effect of treating a vessel with plaque excision (PE) in combination with paclitaxel-coated balloon angioplasty (PTX PTA) compared to treatment with PTX PTA alone.

研究设计

研究类型
Observational
观察模型
Cohort

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Was a subject in DEFINITIVE AR I
  • Is able and willing to provide written informated consent prior to study specific data collection.

排除标准

  • Withdrew consent in DEFINITIVE AR I.
  • Was reported dead during DEFINITIVE AR I.

结局指标

主要结局

Major Adverse Event Rate

时间窗: 2 years

次要结局

未报告次要终点

研究者

发起方
Medtronic Endovascular
申办方类型
Industry
责任方
Sponsor

相似试验